The New York Times editorial board recently observed: “We shouldn’t be surprised by any biotech’s failure. We should expect it. Biotechs by their nature offer the promise of disruptive breakthroughs and discoveries, but they’re mostly all-in propositions, based on one molecule or one test. Fail in a Phase III clinical trial — and a majority do — […]
Smithsonian magazine publishes story about impact of MSU alum, vaccinologist Maurice Hilleman From MSU News Service FEBRUARY 23, 2018 BOZEMAN — The work and impact of a Montana State University alumnus was featured recently in a prominent national forum. “You Should Thank Maurice Hilleman for Helping You Live Past the Age of 10”was published […]
The BIO Investor Forum is the premier event for emerging private and public companies to connect with prospective investors to make the deals that drive our industry. More than 220 investors are already registeredfor this year, with one month to go. The foundation for the success of an event of such magnitude as BIO Investor Forum rests on […]
Climbing The Funding Ladder in Research and Drug Development
Now Accepting Applications for Three ITHS Career Development Programs
Stan Abel of SiteOne Therapeutics to Serve as Chairman Of the Board of Montana’s Leading Biotechnology Innovation Organization; Jay Evans of Inimmune and Tim Layton of Genentech Elected to the Board of Directors Billings, MT – Wednesday, August 16, 2017 – The Montana BioScience Alliance recently elected three new board members and appointed new […]
Article originally posted at: http://www.montana.edu/news/17049/msu-scientist-publishes-findings-that-may-explain-how-cancerous-tumors-survive-after-treatment BOZEMAN – A Montana State University scientist recently published research that may explain how some cancerous tumors persist and continue to grow even after undergoing treatments that kill the cancerous cells. The new findings were published in June in the journal Cell Reports and come from furthering research published two years […]
Washington, DC (August 3, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement regarding passage of the Food and Drug Administration Reauthorization Act (FDARA) by the U.S. Senate today: “The user fee program reauthorization package passed by the Senate today is an important victory for patients and for the […]
NCATS SBIR/STTR Applications Due Sept. 5, 2017 The National Center for Advancing Translational Sciences (NCATS) has several open Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program funding opportunities. SBIR and STTR funding supports small business entrepreneurs working on the advancement and commercialization of translational research technologies. NCATS is particularly interested in applications focused on […]
Expect to laugh and learn when microbiologist, comedian, author, storyteller and television presenter Adam Ruben takes the stage at the Hamilton Performing Arts Center (PAC) on Friday, May 5, at 7 p.m. The PAC is located at 327 Fairgrounds Road. 2017 spring Adam RubenRuben’s presentation, titled “Public Perception of Science: Lessons from a Dead Sheep,” […]
The ITHS Translational Research Scholars Program (formerly Rising Stars) is now accepting applications for our 2017 cohort. The program welcomes early stage investigators from the WWAMI-region. BENEFITS The program offers a high-quality, targeted, and structured career development package for one year. Benefits include: $10,000 in funding to conduct research and develop career skills Mentorship from established translational […]
Two dozen good-paying scientific research jobs almost left western Montana for Maryland last year – but they ended up here in Missoula thanks to an innovative partnership with the University of Montana. GlaxoSmithKline Vaccines, a giant pharmaceutical company with an office in Hamilton, announced in February 2015 that it was consolidating its research and development […]
